155 related articles for article (PubMed ID: 12088859)
1. Albendazole-soybean oil emulsion for the treatment of human cystic echinococcosis: evaluation of bioavailability and bioequivalence.
Mingjie W; Shuhua X; Junjie C; Bin L; Cheng F; Weixia S; Hotez P
Acta Trop; 2002 Aug; 83(2):177-81. PubMed ID: 12088859
[TBL] [Abstract][Full Text] [Related]
2. Augmented bioavailability and cysticidal activity of albendazole reformulated in soybean emulsion in mice infected with Echinococcus granulosus or Echinococcus multilocularis.
Shuhua X; Jiqing Y; Mingjie W; Pieying J; Fanghua G; Junjie C; Wei J; Hotez P
Acta Trop; 2002 Apr; 82(1):77-84. PubMed ID: 11904106
[TBL] [Abstract][Full Text] [Related]
3. Observations on clinical efficacy of albendazole emulsion in 264 cases of hepatic cystic echinococcosis.
Chai J; Menghebat ; Wei J; Deyu S; Bin L; Jincao S; Chen F; Xiong L; Yiding M; Xiuling W; Dolikun ; Guliber ; Yanchun W; Fanghua G; Shuhua X
Parasitol Int; 2004 Mar; 53(1):3-10. PubMed ID: 14984830
[TBL] [Abstract][Full Text] [Related]
4. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep.
Ceballos L; Virkel G; Elissondo C; Canton C; Canevari J; Murno G; Denegri G; Lanusse C; Alvarez L
Acta Trop; 2013 Sep; 127(3):216-25. PubMed ID: 23692888
[TBL] [Abstract][Full Text] [Related]
5. Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations.
Ceballos L; Elissondo C; Moreno L; Dopchiz M; Sánchez Bruni S; Denegri G; Alvarez L; Lanusse C
Parasitol Res; 2008 Jul; 103(2):355-62. PubMed ID: 18465143
[TBL] [Abstract][Full Text] [Related]
6. Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice.
Pensel PE; Ullio Gamboa G; Fabbri J; Ceballos L; Sanchez Bruni S; Alvarez LI; Allemandi D; Benoit JP; Palma SD; Elissondo MC
Acta Trop; 2015 Dec; 152():185-194. PubMed ID: 26409727
[TBL] [Abstract][Full Text] [Related]
7. Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.
Lötsch F; Naderer J; Skuhala T; Groger M; Auer H; Kaczirek K; Waneck F; Ramharter M
Parasitol Res; 2016 Aug; 115(8):2995-3001. PubMed ID: 27085708
[TBL] [Abstract][Full Text] [Related]
8. Effect of dose increase or cimetidine co-administration on albendazole bioavailability.
Schipper HG; Koopmans RP; Nagy J; Butter JJ; Kager PA; Van Boxtel CJ
Am J Trop Med Hyg; 2000; 63(5-6):270-3. PubMed ID: 11421376
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration.
Li Z; Chen C; Ai D; Wang C; Li J; Qi Y; Yi W; Shen H; Cao J
Environ Toxicol Pharmacol; 2012 Mar; 33(2):197-204. PubMed ID: 22227164
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
Abulaihaiti M; Wu XW; Qiao L; Lv HL; Zhang HW; Aduwayi N; Wang YJ; Wang XC; Peng XY
PLoS Negl Trop Dis; 2015; 9(9):e0003950. PubMed ID: 26352932
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole.
García JJ; Bolás F; Torrado JJ
Int J Pharm; 2003 Jan; 250(2):351-8. PubMed ID: 12527162
[TBL] [Abstract][Full Text] [Related]
12. Time dependent pharmacokinetics of albendazole in human.
Mirfazaelian A; Rouini MR; Dadashzadeh S
Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
Darvishi MM; Moazeni M; Alizadeh M; Abedi M; Tamaddon AM
Parasitol Res; 2020 Dec; 119(12):4233-4241. PubMed ID: 32996050
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of albendazole chitosan microspheres against Echinococcus granulosus infection in mice].
Liang W; Wang XC; Wu XW; Zhang SJ; Sun H; Ma X; Peng XY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Jun; 32(3):188-92. PubMed ID: 25223052
[TBL] [Abstract][Full Text] [Related]
15. Disposition kinetics of albendazole and metabolites in laying hens.
Bistoletti M; Alvarez L; Lanusse C; Moreno L
J Vet Pharmacol Ther; 2013 Apr; 36(2):161-8. PubMed ID: 22533477
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
Lanchote VL; Garcia FS; Dreossi SA; Takayanagui OM
Ther Drug Monit; 2002 Jun; 24(3):338-45. PubMed ID: 12021623
[TBL] [Abstract][Full Text] [Related]
17. Dose dependent pharmacokinetics of albendazole in human.
Mirfazaelian A; Rouini MR; Dadashzadeh S
Biopharm Drug Dispos; 2002 Dec; 23(9):379-83. PubMed ID: 12469331
[TBL] [Abstract][Full Text] [Related]
18. Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis.
Dvoroznáková E; Hrcková G; Borosková Z; Velebný S; Dubinský P
Parasitol Int; 2004 Dec; 53(4):315-25. PubMed ID: 15464441
[TBL] [Abstract][Full Text] [Related]
19. In vivo effect of oral albendazole and albendazole sulphoxide on development of secondary echinococcosis in mice.
Pérez-Serrano J; Denegri G; Casado N; Rodríguez-Caabeiro F
Int J Parasitol; 1997 Nov; 27(11):1341-5. PubMed ID: 9421721
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
Capece BP; Castells G; Godoy C; Arboix M; Cristòfol C
Vet J; 2008 Aug; 177(2):297-9. PubMed ID: 17566773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
